(1S,2R,4S,5S)-2-((S)-Hydroxy(6-methoxyquinolin-4-yl)methyl)-1-(4-(trifluoromethyl)benzyl)-5-vinylquinuclidin-1-ium bromide

97%

Reagent Code: #236824
fingerprint
CAS Number 217299-07-5

science Other reagents with same CAS 217299-07-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 563.45 g/mol
Formula C₂₈H₃₀BrF₃N₂O₂
inventory_2 Storage & Handling
Storage 2-8°C, Inert Gas

description Product Description

Used in the treatment of respiratory diseases, particularly as a long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, leading to improved airflow and reduced symptoms such as wheezing and shortness of breath. The compound is designed for inhalation delivery, allowing targeted action in the lungs with minimal systemic side effects. Its structure supports prolonged receptor binding, enabling once-daily dosing in clinical settings.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿2,260.00
inventory 250mg
10-20 days ฿3,380.00
inventory 1g
10-20 days ฿8,450.00
inventory 5g
10-20 days ฿32,000.00
(1S,2R,4S,5S)-2-((S)-Hydroxy(6-methoxyquinolin-4-yl)methyl)-1-(4-(trifluoromethyl)benzyl)-5-vinylquinuclidin-1-ium bromide
No image available

Used in the treatment of respiratory diseases, particularly as a long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, leading to improved airflow and reduced symptoms such as wheezing and shortness of breath. The compound is designed for inhalation delivery, allowing targeted action in the lungs with minimal systemic side effects. Its structure supports prolonged receptor binding, enabling once-daily dosing in c

Used in the treatment of respiratory diseases, particularly as a long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, leading to improved airflow and reduced symptoms such as wheezing and shortness of breath. The compound is designed for inhalation delivery, allowing targeted action in the lungs with minimal systemic side effects. Its structure supports prolonged receptor binding, enabling once-daily dosing in clinical settings.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...